Shareholder Activities

2019-2020 NWCRI Shareholder Activities

NWCRI members are bringing 14 justice issues to the boardrooms of 48 corporations, filing 31 shareholder resolutions* and participating in over 50 dialogues.

Company Issue
Action
AbbVie Executive Compensation & Drug Pricing Risks
Resolution
24%
AbbVie Global Health
Dialogue
Alphabet Child Sexual Exploitation Online
Agreement
Altria Group* Discourage Nicotine Use Among Youth
Resolution 37%
Amazon Facial Recognition Software-Customer Due Diligence
Resolution 32%
Amer. Outdoors Brands Develop a Human Rights Policy
Resolution
Amgen Senior Executive Incentives – Integrate Drug Pricing Risk
Agreement
AT&T Child Sexual Exploitation Online
Dialogue
Biogen Executive Compensation & Drug Pricing Risks
Agreement
Bristol-Myers Squibb* Independent Board Chair
Resolution 45%
Bristol-Myers Squibb Global Health
Dialogue
Campbell Soup Health Outcomes Related to Diet/Human Right to Water
Dialogue
Cardinal Health Establish Deferral Period for Senior Exec Bonuses
Agreement
Caterpillar Lobbying Expenditures Disclosure
Resolution 34%
Chevron* Evaluation of Human Rights Practices
Resolution 17%
Chevron Plans to Align Operations with Paris Treaty
Resolution Omitted
Coca-Cola Water Stewardship/Sustainable Agriculture
Dialogue
Comcast* Lobbying Expenditures Disclosure
Resolution 26%
CoreCivic Private Prisons/Human Rights Due Diligence
Dialogue
CVS Health Establish Deferral Period for Senior Exec Bonuses
Agreement
Disney Tobacco Depiction Policy in Media
Dialogue
Dick’s Sporting Goods Gun Safety
Dialogue
Duke Energy* Report on Mitigation of Health & Climate Impacts of Coal
Agreement
Eli Lilly Executive Compensation & Drug Pricing Risks
Resolution 24%
Eli Lilly Global Health
Dialogue
ExxonMobil Plans to Align Operations with Paris Treaty
Resolution Omitted
Facebook Independent Board Chair
Resolution 20%
Freeport McMoRan Human Rights
Dialogue
General Mills Health Outcomes Related to Diet
Dialogue
GEO Group Private Prisons/Human Rights Due Diligence
Dialogue
Gilead Sciences Independent Board Chair
Resolution 44%
Gilead Sciences Global Health
Dialogue
Hershey Human Rights Due Diligence in Supply Chain
Dialogue
Johnson & Johnson Board Report on Oversight of Opioids
Resolution 61%
Johnson & Johnson Independent Board Chair
Resolution 42%
Johnson & Johnson Global Health
Dialogue
JP Morgan Chase Project Financing in Arctic & Canadian Oil Sands Resolution 15%
Kraft Heinz Human Rights Dialogue
Kroger Human Rights Due Diligence in Supply Chain
Dialogue
McDonald’s Health Outcomes Related to Diet
Dialogue
Merck Global Health
Dialogue
Merck Senior Executive Incentives – Integrate Drug Pricing Risk
Agreement
Mylan Monitor & Manage Risks Related to Opioids
Dialogue
Newmont Mining Human Rights Supplier Standards
Dialogue
Northrop Grumman* Human Rights Supplier Standards
Resolution 24%
Olin Safety in Firearms Industry-Ammunition
Agreement
PepsiCo Water/Reduce Pesticide/Pollinator Health
Dialogue
Pfizer Executive Compensation & Drug Pricing Risks
Agreement
Pfizer Global Health
Dialogue
Pfizer Independent Board Chair
Resolution 34%
Sanofi Global Health/Drug Pricing
Dialogue
Sturm Ruger Human Rights Impact Assessment
Agreement
Tyson Foods Human Rights Due Diligence
Resolution 14.58%
Walgreens Boot Alliance Establish Deferral Period for Senior Exec Bonuses
Agreement
Walgreens Boot Alliance Tobacco Sales
Dialogue
Walmart* Board Oversight – Risks Related to Opioids
Agreement
Walmart Wages & Benefits for Employees
Dialogue
Walmart Human Rights Due Diligence in Supply Chain
Dialogue
Walmart Gun Safety
Dialogue
Wells Fargo Business Standards/Vision & Values/Risk Management
Dialogue

*Resolutions filed by the Sisters of St. Francis of Philadelphia from their office